MDPI and ACS Style
Rutz, J.; Maxeiner, S.; Grein, T.; Sonnenburg, M.; Khadir, S.E.; Makhatelashvili, N.; Mann, J.; Xie, H.; Cinatl, J.; Thomas, A.;
et al. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. Int. J. Mol. Sci. 2022, 23, 10996.
https://doi.org/10.3390/ijms231910996
AMA Style
Rutz J, Maxeiner S, Grein T, Sonnenburg M, Khadir SE, Makhatelashvili N, Mann J, Xie H, Cinatl J, Thomas A,
et al. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. International Journal of Molecular Sciences. 2022; 23(19):10996.
https://doi.org/10.3390/ijms231910996
Chicago/Turabian Style
Rutz, Jochen, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Salma El Khadir, Nino Makhatelashvili, Johanna Mann, Hui Xie, Jindrich Cinatl, Anita Thomas,
and et al. 2022. "Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines" International Journal of Molecular Sciences 23, no. 19: 10996.
https://doi.org/10.3390/ijms231910996